ストックスクリーナーアプリを入手
42.72
1.97%
-0.86
前日終値:
$43.58
開ける：
$45.38
24時間の取引高:
594.12K
Relative Volume:
0.48
時価総額：
$3.40B
収益：
-
当期純損益:
$-237.22M
株価収益率:
-11.30
EPS:
-3.78
ネットキャッシュフロー:
$-212.64M
1週間 パフォーマンス:
-5.53%
1か月 パフォーマンス:
-10.53%
6か月 パフォーマンス:
+51.27%
1年 パフォーマンス:
+69.12%
1日の値動き範囲:
$42.26
$45.38
1週間の範囲:
$41.84
$46.14
52週間の値動き範囲:
$17.86
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
名前
Akero Therapeutics Inc
セクター
電話
650-487-6488
住所
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
AKRO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
42.72 | 3.40B | 0 | -237.22M | -212.64M | -3.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-30 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-01-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-11-18 | 開始されました | Citigroup | Buy |
| 2024-04-22 | 再開されました | BofA Securities | Neutral |
| 2023-09-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-08-28 | 開始されました | UBS | Buy |
| 2023-01-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-10-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-02-26 | 開始されました | Guggenheim | Buy |
| 2020-09-10 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-07 | 開始されました | Chardan Capital Markets | Buy |
| 2020-07-01 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-02 | 開始されました | H.C. Wainwright | Buy |
| 2020-02-10 | 開始されました | Canaccord Genuity | Buy |
| 2019-07-15 | 開始されました | Evercore ISI | Outperform |
| 2019-07-15 | 開始されました | JP Morgan | Overweight |
| 2019-07-15 | 開始されました | Jefferies | Buy |
| 2019-07-15 | 開始されました | ROTH Capital | Buy |
すべてを表示
Akero Therapeutics Inc (AKRO) 最新ニュース
Akero Therapeutics (NASDAQ:AKRO) Shares Gap Up Following Insider Buying Activity - MarketBeat
How To Trade (AKRO) - Stock Traders Daily
G. Walmsley Graham Purchases 91,309 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat
Proficio Capital Partners LLC Purchases Shares of 11,490 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Akero Therapeutics Insider Bought Shares Worth $8,787,921, According to a Recent SEC Filing - Marketscreener.com
Simplify Asset Management Inc. Sells 19,089 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Acquired by Swiss National Bank - Defense World
Akero Therapeutics director Graham Walmsley buys $8.79m in stock By Investing.com - Investing.com South Africa
Akero Therapeutics director Graham Walmsley buys $8.79m in stock - Investing.com India
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 6.3%Here's Why - MarketBeat
Proficio Capital Partners LLC Invests $320,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Intech Investment Management LLC Buys 20,795 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Yiheng Capital Management L.P. Sells 92,624 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
There is no way Akero Therapeutics Inc (AKRO) can keep these numbers up - SETE News
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Alumis and Kaken sign agreement in Japan for ESK-001 - Pharmaceutical Technology
Charles Schwab Investment Management Inc. Acquires 8,096 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands - Bluefield Daily Telegraph
Notice to Long-Term Shareholders of Akero Therapeutics, - GlobeNewswire
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is I - TradingView
Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Investors to Connect - Markets Insider
Kennondale Capital Management LLC Acquires New Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Catriona Yale Sells 10,000 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Position Raised by Charles Schwab Investment Management Inc. - Defense World
Bank of New York Mellon Corp Sells 6,414 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Stockholders to Inquire about Securities Investigation - Markets Insider
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Bought by AlphaQuest LLC - MarketBeat
Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Sells 1,738 Shares of Stock - MarketBeat
How to Take Advantage of moves in (AKRO) - Stock Traders Daily
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $27,556.32 in Stock - MarketBeat
Akero therapeutics chief development officer sells $447,605 in stock By Investing.com - Investing.com Australia
Akero therapeutics chief development officer sells $447,605 in stock - Investing.com India
Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells $27,242.16 in Stock - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO William Richard White Sells 676 Shares - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Andrew Cheng Sells 30,000 Shares - MarketBeat
Bank of New York Mellon Corp Cuts Stock Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Great Lakes Advisors LLC Makes New $5.38 Million Investment in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (NASDAQ:AKRO) Stock Price Up 5.5%Time to Buy? - MarketBeat
Akero Therapeutics Inc (AKRO) 財務データ
収益
当期純利益
現金流量
EPS
Akero Therapeutics Inc (AKRO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Graham G. Walmsley | Director |
Mar 26 '25 |
Buy |
43.01 |
58,691 |
2,524,417 |
1,150,000 |
| Graham G. Walmsley | Director |
Mar 27 '25 |
Buy |
43.55 |
50,000 |
2,177,700 |
1,200,000 |
| Yale Catriona | Chief Development Officer |
Mar 17 '25 |
Option Exercise |
21.10 |
10,000 |
211,000 |
105,034 |
| Yale Catriona | Chief Development Officer |
Mar 17 '25 |
Sale |
44.76 |
10,000 |
447,605 |
95,034 |
| Cheng Andrew | President and CEO |
Mar 12 '25 |
Sale |
44.88 |
1,738 |
78,001 |
654,324 |
| Young Jonathan | Chief Operating Officer |
Mar 12 '25 |
Sale |
44.88 |
607 |
27,242 |
200,540 |
| Yale Catriona | Chief Development Officer |
Mar 12 '25 |
Sale |
44.88 |
614 |
27,556 |
95,034 |
| White William Richard | Chief Financial Officer |
Mar 12 '25 |
Sale |
44.88 |
676 |
30,339 |
61,959 |
| Rolph Timothy | Chief Scientific Officer |
Mar 12 '25 |
Sale |
44.88 |
516 |
23,158 |
169,721 |
| Cheng Andrew | President and CEO |
Mar 10 '25 |
Sale |
41.77 |
30,000 |
1,253,069 |
656,062 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):